Modeling fatty liver disease in vitro

Discover more from the In Focus here: bit.ly/3M4fiim
Including an infographic on the pros and cons of various disease models: bit.ly/38ZINEr
And a podcast on the non-alcoholic steatohepatitis therapeutic landscape and the incorporation organ-on-a-chip models into drug discovery workflows: bit.ly/3aytZgv
Introducing our In Focus on modeling disease with organ-on-a-chip technologies, this video explores non-alcoholic fatty liver disease and the benefits of incorporating liver-on-a-chip models into drug discovery workflows.